Home Cart 0 Sign in  
X

[ CAS No. 22282-99-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 22282-99-1
Chemical Structure| 22282-99-1
Chemical Structure| 22282-99-1
Structure of 22282-99-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 22282-99-1 ]

Related Doc. of [ 22282-99-1 ]

Alternatived Products of [ 22282-99-1 ]

Product Details of [ 22282-99-1 ]

CAS No. :22282-99-1 MDL No. :MFCD03788196
Formula : C6H6BrN Boiling Point : -
Linear Structure Formula :- InChI Key :JFBMFWHEXBLFCR-UHFFFAOYSA-N
M.W : 172.02 Pubchem ID :2762835
Synonyms :
4-Bromo-2-picoline

Calculated chemistry of [ 22282-99-1 ]

Physicochemical Properties

Num. heavy atoms : 8
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.17
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 0.0
Molar Refractivity : 36.9
TPSA : 12.89 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.09 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.91
Log Po/w (XLOGP3) : 1.78
Log Po/w (WLOGP) : 2.15
Log Po/w (MLOGP) : 1.58
Log Po/w (SILICOS-IT) : 2.54
Consensus Log Po/w : 1.99

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.58
Solubility : 0.449 mg/ml ; 0.00261 mol/l
Class : Soluble
Log S (Ali) : -1.67
Solubility : 3.69 mg/ml ; 0.0214 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -3.26
Solubility : 0.0948 mg/ml ; 0.000551 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.41

Safety of [ 22282-99-1 ]

Signal Word:Warning Class:
Precautionary Statements:P280-P305+P351+P338 UN#:
Hazard Statements:H302-H315-H319-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 22282-99-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 22282-99-1 ]
  • Downstream synthetic route of [ 22282-99-1 ]

[ 22282-99-1 ] Synthesis Path-Upstream   1~29

  • 1
  • [ 18437-58-6 ]
  • [ 22282-99-1 ]
YieldReaction ConditionsOperation in experiment
92%
Stage #1: With hydrogen bromide; sodium nitrite In water at -10 - 20℃; for 16.5 h;
4-Bromo-2-methylpyridine (153)A stirred solution of amino-pyridine 152 (10.1 g, 93.4 mmol) in 48percent aqueous HBr (165 mL) at -10"C is treated with a pre-cooled (0°C) solution of sodium nitrite (7.04 g, 0.102 mol) in water (165 mL) dropwise over 0.5 h. The solution is then warmed to RT and stirred 16 h. It is then diluted with 4 M NaOH (400 mL) and extracted into TBME (4 x 150 mL). The TBME phases are combined, dried (MgSO4) and reduced in vacuo to afford the title compound. Yield: 14.8 g (92percent). LC/MS tτ 0.57 min. MS(ES+) m/z 174, 172 (M+H).
92% With hydrogen bromide; sodium nitrite In water at -10 - 20℃; for 16.5 h; 4-Bromo-2-methylpyridine (153)A stirred solution of amino-pyridine 152 (10.1 g, 93.4 mmol) in 48percent aqueous HBr (165 mL) at -10°C was treated with a pre-cooled (0°C) solution of sodium nitrite <n="205"/>(7.04 g, 0.102 mol) in water (165 mL) dropwise over 0.5 h. The solution was then warmed to RT and stirred 16 h. It was then diluted with 4 M NaOH (400 mL) and extracted into TBME (4 x 150 mL). The TBME phases were combined, dried(MgSO4) and reduced in vacuo to afford the title compound.Yield: 14.8 g (92percent).LC/MS tr 0.57 rain.MS(ES+) m/z 174, 172 (M+H).
92%
Stage #1: With hydrogen bromide; sodium nitrite In water at -10 - 20℃; for 16.5 h;
4-Bromo-2-methylpyridine (153); A stirred solution of amino-pyridine 152 (10.1 g, 93.4 mmol) in 48percent aqueous HBr (165 mL) at -10°C is treated with a pre-cooled (0°C) solution of sodium nitrite (7.04 g, 0.102 mol) in water (165 mL) dropwise over 0.5 h. The solution is then warmed to RT and stirred 16 h. It is then diluted with 4 M NaOH (400 mL) and extracted into TBME (4 x 150 mL). The TBME phases are combined, dried (MgSO4) and reduced in vacuo to afford the title compound. Yield: 14.8 g (92percent). LC/MS U 0.57 min. MS(ES+) m/z 174, 172 (M+H).
92%
Stage #1: With hydrogen bromide; sodium nitrite In water at 0 - 20℃; for 16.5 h;
Stage #2: With sodium hydroxide In water
4-Bromo-2-methylpyridine (153); A stirred solution of amino-pyridine 152 (10.1 g, 93.4 mmol) in 48percent aqueous HBr(165 mL) at -10°C is treated with a pre-cooled (0°C) solution of sodium nitrite (7.04 g, 0.102 mol) in water (165 mL) dropwise over 0.5 h. The solution is then warmed toRT and stirred 16 h. It is then diluted with 4 M NaOH (400 mL) and extracted into TBME (4 x 150 mL). The TBME phases are combined, dried (MgSO4) and reduced in vacuo to afford the title compound.Yield: 14.8 g (92percent).LC/MS /, 0.57 min.MS(ES+) m/z 174, 172 (M+H).
89%
Stage #1: With hydrogen bromide; sodium nitrite In water at -15 - 15℃;
Stage #2: With copper(I) bromide In water at -15 - 20℃; for 12 h;
-Methyl-4-aminopyridine (3. 86 g, 35.69 mmol) in [48percent] aqueous HBr (24 [ML)] was cooled to -15°C and [NAN02] (4.9 g, 71.4 mmol) in water (34 mL) was added slowly. (Note: The temperature was maintained between-10 to [15 °C] during the addition. ) CuBr [(510 MG,] 3.6 mmol) was added to the above reaction mixture at-15° C and slowly allowed to warm to room temperature over 12 hours. The pH of the reaction mixture was adjusted to [PH =10,] by addition [OF NAOH (11 G] in 21 mL water). The reaction mixture was filtered through celite and washed with ether/water. The layers were separated and the aqueous layer was extracted twice with ether. The combined organic extracts were dried [(NA2SO4),] concentrated under vacuum, and purified by silica gel chromatography (50percent ether in hexanes) to afford [4-BROMO-2-METHYLPYRIDINE] [(5.] 48 g, 89percent yield).

Reference: [1] Patent: WO2008/57497, 2008, A2, . Location in patent: Page/Page column 292
[2] Patent: WO2007/89669, 2007, A2, . Location in patent: Page/Page column 203-204
[3] Patent: WO2008/57469, 2008, A1, . Location in patent: Page/Page column 292
[4] Patent: WO2008/57468, 2008, A1, . Location in patent: Page/Page column 292
[5] Patent: WO2004/14913, 2004, A2, . Location in patent: Page 81-82
[6] Journal fuer Praktische Chemie (Leipzig), 1959, vol. &lt;4&gt; 9, p. 164,172
[7] Roczniki Chemii, 1959, vol. 33, p. 387,392[8] Chem.Abstr., 1959, p. 18954
  • 2
  • [ 676-58-4 ]
  • [ 19524-06-2 ]
  • [ 22282-99-1 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2010, vol. 18, # 2, p. 630 - 639
[2] Patent: WO2009/118292, 2009, A1, . Location in patent: Page/Page column 83-84
  • 3
  • [ 75-16-1 ]
  • [ 19524-06-2 ]
  • [ 22282-99-1 ]
Reference: [1] Patent: US6642237, 2003, B1, . Location in patent: Page/Page column 165-166
  • 4
  • [ 131747-63-2 ]
  • [ 22282-99-1 ]
Reference: [1] Patent: US2007/4730, 2007, A1, . Location in patent: Page/Page column 12
  • 5
  • [ 13508-96-8 ]
  • [ 506-96-7 ]
  • [ 22282-99-1 ]
Reference: [1] Patent: US5705499, 1998, A,
[2] Patent: EP767172, 1997, A1,
[3] Pharmaceutical bulletin, 1954, vol. 2, # 2, p. 147 - 149
  • 6
  • [ 5470-66-6 ]
  • [ 22282-99-1 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1990, vol. 38, # 9, p. 2446 - 2458
[2] Pharmaceutical bulletin, 1954, vol. 2, # 2, p. 147 - 149
[3] Patent: WO2008/57469, 2008, A1,
[4] Patent: WO2008/57468, 2008, A1,
  • 7
  • [ 13508-96-8 ]
  • [ 22282-99-1 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1990, vol. 38, # 9, p. 2446 - 2458
  • 8
  • [ 19524-06-2 ]
  • [ 22282-99-1 ]
Reference: [1] Synthesis, 2002, # 6, p. 749 - 752
  • 9
  • [ 931-19-1 ]
  • [ 22282-99-1 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1990, vol. 38, # 9, p. 2446 - 2458
  • 10
  • [ 67-66-3 ]
  • [ 7789-60-8 ]
  • [ 22282-99-1 ]
Reference: [1] Pharmaceutical bulletin, 1954, vol. 2, # 2, p. 147 - 149
  • 11
  • [ 22282-99-1 ]
  • [ 22282-65-1 ]
Reference: [1] Angewandte Chemie - International Edition, 2015, vol. 54, # 1, p. 263 - 266[2] Angew. Chem., 2015, vol. 127, # 01, p. 265 - 268,4
  • 12
  • [ 22282-99-1 ]
  • [ 68-12-2 ]
  • [ 63875-01-4 ]
YieldReaction ConditionsOperation in experiment
85% With n-butyllithium In tetrahydrofuran; hexane; N,N-dimethyl-formamide at -78℃; for 1.58333 h; Example 117
Preparation of 2-(2-methylpyridin-4-yl)-6-(morpholinomethyl)quinazolin-4(3H)-one
A solution of n-butyllithium (1.6 M solution in hexanes, 6.32 mL, 12.6 mmol) in THF (50 mL) was cooled to -78° C. A solution of 4-bromo-2-methyl-pyridine (2.00 g, 11.6 mmol.) in anhydrous THF (5 mL) was added.
The resulting mixture was stirred for 5 minutes, then anhydrous N,N dimethylformamide (3.39 g, 46.4 mmol,) was added.
The solution was stirred for 90 min at -78° C. and quenched with saturated aqueous NH4Cl solution (30 mL).
The reaction mixture was warmed to room temperature.
The mixture was extracted with ethyl acetate (3*100 mL), and the combined organic phase was washed with brine (100 mL) and dried over anhydrous Na2SO4.
The solvent was evaporated under reduced pressure to give 2-methyl-pyridine-4-carbaldehyde. Yield: 1.20 g, (85percent).
30%
Stage #1: With n-butyllithium In diethyl ether at -78℃; for 0.25 h; Inert atmosphere
Stage #2: at 0℃; for 0.5 h;
To a stirred solution of 4-bromo-2-methylpyridine (1.00 g, 5.81 mmol) in anhydrous diethyl ether (70 mL) was added n-BuLi (2.5 M, 2.56 mL, 6.39 mmol) at -78 °C under N2. After stirring at -78 °C for 15 mi DMF (0.54 mL, 6.92 mmol) was added slowly. The mixture was stirred for another 30 mm and warmed to 0 °C. The mixture was quenched with 20 mL of aq. NaHCO3, extracted with EA (50 mL x 2). The combined organics was washed with brine (50 mL x 2), dried over anhydrous Na2SO4, filtered and concentrated. The resulted residue was purified by column chromatography eluted with PE/EA (5:1) to give the title product (210 mg, 30percent) as a light yellow solid. ‘HNMR (400 MHz, CDCl) 10.05 (s, 1H),8.76 (d, J=4.8 Hz, 1H),7.56 (s, 1H),7.51 (d, J=4.8 Hz, 1H), 2.68 (s, 3H)
1 g
Stage #1: With tert.-butyl lithium In diethyl ether at -78℃; for 0.5 h; Inert atmosphere
Stage #2: at -78℃; for 0.5 h; Inert atmosphere
Intermediate H: Preparation of 2-methylisonicotinaldehyde Under a nitrogen atmosphere, to a solution of 4-bromo-2-methylpyridine (2.00 g, 11.63 mmol) in anhydrous Et20 (150 mL) was added t-butyllithium (0.82 g, 12.79 mmol) at -78 °C. The reaction was kept at that temperature for 30 min. Anhydrous DMF (0.85 g, 11.63 mmol) was added and the mixture was stirred at -78 °C for an additional 30 min. Saturated aqueous NH4C1 (50 mL) was added to the reaction vessel and the resulting biphasic mixture was transferred to a separatory funnel. The layers were washed with Et20 (6 x 50 mL). The combined organics were washed with saturated NaCl (2 x 50 mL), dried over anhydrous Na2S04, filtered and concentrated in vacuo to provide 2-methylisonicotinaldehyde (lg, 8.3 mmol). GCMS [M] = 121
Reference: [1] Patent: US9238640, 2016, B2, . Location in patent: Page/Page column 145
[2] Patent: WO2017/88755, 2017, A1, . Location in patent: Paragraph 000119; 000120; 000121
[3] Patent: WO2015/88565, 2015, A1, . Location in patent: Paragraph 00217
[4] Patent: WO2015/88564, 2015, A1, . Location in patent: Paragraph 00243
  • 13
  • [ 22282-99-1 ]
  • [ 84249-14-9 ]
Reference: [1] Patent: WO2008/57469, 2008, A1,
[2] Patent: WO2008/57468, 2008, A1,
  • 14
  • [ 22282-99-1 ]
  • [ 94413-70-4 ]
Reference: [1] Pharmaceutical bulletin, 1954, vol. 2, # 2, p. 147 - 149
  • 15
  • [ 22282-99-1 ]
  • [ 105250-16-6 ]
Reference: [1] Patent: WO2011/38086, 2011, A2,
  • 16
  • [ 22282-99-1 ]
  • [ 201230-82-2 ]
  • [ 16830-24-3 ]
Reference: [1] Patent: WO2011/38086, 2011, A2, . Location in patent: Page/Page column 85-86
  • 17
  • [ 22282-99-1 ]
  • [ 30766-03-1 ]
YieldReaction ConditionsOperation in experiment
33% With potassium permanganate In water at 80℃; 4.1.12
5-Bromopyridine-2-carboxylic acid (16)
In a 250 mL three-necked flask equipped with a stirrer, a thermometer, and a condenser, 100 mL water and 4-bromo-2-methylpyridine (15) (4.0 g, 23 mmol) was added to it and stirring until the temperature was raised to 80 °C, then KMnO4 (16.6 g, 105 mmol) was added in three batches at intervals of 1 h.
The mixture was stirred at the same temperature for 3-4 h.
Suction filtration to give a clear solution, the solution was adjusted to pH 4-5 with concentrated HCl, some white solid precipitated, the filter cake is a small amount of the product (16).
After filtration and concentration in vacuo, an appropriate amount of ethanol was added to the residues to dissolve the residue compound (16), a lot of white solid precipitated, discarded it after subjected to suction filtration again, finally the filtrate was concentrated in vacuo, total yielding (16) (1.70 g, 33percent) as light yellow solid.
22%
Stage #1: at 20℃; for 6.5 h; Heating / reflux
4-Bromopyridine-2-carboxylic acid (154) EPO <DP n="294"/>A stirred solution of pyridyl bromide 153 (5.03 g, 29.0 mmol) in water (130 mL) is treated at RT with KMnO4 (4.72 g, 29.5 mmol) in one portion then heated to reflux 1.5 h. At this juncture more KMnO4 is added (4.72 g, 29.5 mmol) and the solution heated at reflux a further 2 h. Another portion of KMnO4 is then added (9.43 g, 59 mmol), the reaction heated at reflux a further 3 h then filtered whilst still hot, washing the isolated solids with boiling water (200 mL). The aqueous filtrate is then concentrated in vacuo to approximately 40 mL, acidified to pH 4 by careful addition of 1 M HCl and the resultant white precipitate isolated by filtration. The filtrate is then reduced in vacuo to approximately 10 mL and the forthcoming precipitate also isolated by filtration. Combining these two isolated precipitates gives the title compound. Yield: 1.28 g (22percent). LC/MS U 0.67 min. MS(ES+) m/z 204, 202 (M+H).
22%
Stage #1: for 6.5 h; Heating / reflux
Stage #2: With hydrogenchloride In water
4-Bromopyridine-2-carboxylic acid (154)A stirred solution of pyridyl bromide 153 (5.03 g, 29.0 mmol) in water (130 mL) was treated at RT with KMnO4 (4.72 g, 29.5 mmol) in one portion then heated to reflux 1.5 h. At this juncture more KMnO4 was added (4.72 g, 29.5 mmol) and the solution heated at reflux a further 2 h. Another portion OfKMnO4 was then added (9.43 g, 59 mmol), the reaction heated at reflux a further 3 h then filtered whilst still hot, washing the isolated solids with boiling water (200 mL). The aqueous filtrate was then concentrated in vacuo to approximately 40 mL, acidified to pH 4 by careful addition of 1 M HCl and the resultant white precipitate isolated by filtration. The filtrate was then reduced in vacuo to approximately 10 mL and the forthcoming precipitate also isolated by filtration. Combining these two isolated precipitates gave the title compound. Yield: 1.28 g (22percent). LC/MS tr 0.67 min. MS(ES+) m/z 204, 202 (M+H).
22%
Stage #1: With potassium permanganate In water at 20℃; for 6.5 h; Heating / reflux
4-Bromopyridine-2-carboxylic acid (154); EPO <DP n="294"/>A stirred solution of pyridyl bromide 153 (5.03 g, 29.0 mmol) in water (130 mL) is treated at RT with KMnO4 (4.72 g, 29.5 mmol) in one portion then heated to reflux 1.5 h. At this juncture more KMnO4 is added (4.72 g, 29.5 mmol) and the solution heated at reflux a further 2 h. Another portion OfKMnO4 is then added (9.43 g, 59 mmol), the reaction heated at reflux a further 3 h then filtered whilst still hot, washing the isolated solids with boiling water (200 mL). The aqueous filtrate is then concentrated in vacuo to approximately 40 mL, acidified to pH 4 by careful addition of 1 M HCl and the resultant white precipitate isolated by filtration. The filtrate is then reduced in vacuo to approximately 10 mL and the forthcoming precipitate also isolated by filtration. Combining these two isolated precipitates gives the title compound. Yield: 1.28 g (22percent). LC/MS ty 0.67 min. MS(ES+) m/z 204, 202 (M+H).
22%
Stage #1: With potassium permanganate In water at 20℃; for 6.5 h; Heating / reflux
Stage #2: With hydrogenchloride In water
4-Bromopyridine-2-carboxylic acid (154); A stirred solution of pyridyl bromide 153 (5.03 g, 29.0 mmol) in water (130 mL) is treated at RT with KMnO4 (4.72 g, 29.5 mmol) in one portion then heated to reflux 1.5 h. At this juncture more KMnO4 is added (4.72 g, 29.5 mmol) and the solution heated at reflux a further 2 h. Another portion Of KMnO4 is then added (9.43 g, 59 mmol), the reaction heated at reflux a further 3 h then filtered whilst still hot, washing the isolated solids with boiling water (200 mL). The aqueous filtrate is then concentrated in vacuo to approximately 40 mL, acidified to pH 4 by careful addition of 1 M HCl and the resultant white precipitate isolated by filtration. The filtrate is then reduced in vacuo to approximately 10 mL and the forthcoming precipitate also isolated by filtration. Combining these two isolated precipitates gives the title compound. Yield: 1.28 g (22percent). LC/MS tτ 0.67 min. MS(ES+) m/z 204, 202 (M+H).

Reference: [1] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 13, p. 3228 - 3236
[2] Patent: WO2008/57497, 2008, A2, . Location in patent: Page/Page column 292-293
[3] Patent: WO2007/89669, 2007, A2, . Location in patent: Page/Page column 204
[4] Patent: WO2008/57469, 2008, A1, . Location in patent: Page/Page column 292-293
[5] Patent: WO2008/57468, 2008, A1, . Location in patent: Page/Page column 292-293
[6] Chemical and Pharmaceutical Bulletin, 1990, vol. 38, # 9, p. 2446 - 2458
  • 18
  • [ 22282-99-1 ]
  • [ 55218-73-0 ]
Reference: [1] Journal of Medicinal Chemistry, 2011, vol. 54, # 13, p. 4721 - 4734
  • 19
  • [ 22282-99-1 ]
  • [ 97674-02-7 ]
  • [ 2732-28-7 ]
YieldReaction ConditionsOperation in experiment
44% With tetrakis(triphenylphosphine) palladium(0) In toluene at 80℃; Inert atmosphere To a solution of 4-bromo-2-methylpyridine (10.0 g, 58 mmol) in toluene (100 mL) was added tributyl(l-ethoxyvinyl)stannane (39.7 g, 110 mmol) and Pd(PPh3)4 (5.8 g, 5 mmol). The mixture was stirred at 80 °C under a nitrogen atmosphere overnight. IM HCl was added at 0 °C until the pH of the mixture was adjusted to 1-2. The mixture was stirred for 0.5 h. The pH was adjusted to 6-7 by adding IM NaOH. The mixture was extracted with ethyl acetate (150 mL*3). The organics layer was washed with brine and dried over sodium sulfate. Concentration and purification by column chromatography on silica gel (petroleum ether/ethyl acetate = 30/1-4/1) afforded l-(2-methylpyridin-4-yl)ethanone as light yellow solid (3.0 g, 44percent).
Reference: [1] Patent: WO2016/130396, 2016, A1, . Location in patent: Paragraph 00180; 00181; 00182
  • 20
  • [ 22282-99-1 ]
  • [ 131747-63-2 ]
Reference: [1] Organic and Biomolecular Chemistry, 2012, vol. 10, # 6, p. 1239 - 1245
[2] Chemical and Pharmaceutical Bulletin, 1990, vol. 38, # 9, p. 2446 - 2458
[3] Chemical Science, 2013, vol. 4, # 8, p. 3269 - 3274
  • 21
  • [ 22282-99-1 ]
  • [ 131747-45-0 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1990, vol. 38, # 9, p. 2446 - 2458
[2] Journal of Medicinal Chemistry, 2011, vol. 54, # 13, p. 4721 - 4734
[3] Chemical Science, 2013, vol. 4, # 8, p. 3269 - 3274
[4] Journal of the American Chemical Society, 2014, vol. 136, # 5, p. 1694 - 1697
[5] Patent: WO2015/181797, 2015, A1,
[6] Patent: WO2016/130396, 2016, A1,
  • 22
  • [ 22282-99-1 ]
  • [ 207799-10-8 ]
Reference: [1] Patent: WO2008/57469, 2008, A1,
[2] Patent: WO2008/57468, 2008, A1,
  • 23
  • [ 22282-99-1 ]
  • [ 5419-55-6 ]
  • [ 579476-63-4 ]
Reference: [1] Patent: WO2009/118292, 2009, A1, . Location in patent: Page/Page column 84
  • 24
  • [ 22282-99-1 ]
  • [ 579476-63-4 ]
Reference: [1] Journal of Organic Chemistry, 2013, vol. 78, # 13, p. 6427 - 6439
  • 25
  • [ 22282-99-1 ]
  • [ 73183-34-3 ]
  • [ 660867-80-1 ]
YieldReaction ConditionsOperation in experiment
39% With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate In 1,4-dioxane at 80℃; for 4 h; Inert atmosphere; Sealed tube To a previously degassed solution of 4-bromo-2-methylpidine (0.500 g, 2.906 mmol),4,4,4’,4’,5,5,5’,5’-octamethyl-2,2’-bi( 1 ,3,2-dioxaborolane) (0.812 g, 3.997 mmol),potassium acetate (0.854 g, 8.720 mmol) in 1,4-dioxane (5mL) in 50 mL sealed tube was added [1,1 ‘-bis(diphenylphosphino)ferrocene] dichloropalladium(II) (0.021 g, 0.029 mmol) and stirred at 80°C 4 h. Evaporated off the solvent and purified column chromatography on silica gel (ethyl acetate pet ether = 3070) to give the titledcompound (0.250 g, 39percent) as a off white solid .LCMS: mlz 220.1 [M+H] .
Reference: [1] Patent: WO2014/111871, 2014, A1, . Location in patent: Page/Page column 199
[2] Patent: WO2004/14913, 2004, A2, . Location in patent: Page 82
[3] Patent: US2011/190269, 2011, A1, . Location in patent: Page/Page column 36
[4] Patent: WO2011/92272, 2011, A1, . Location in patent: Page/Page column 73
[5] Patent: WO2011/119518, 2011, A1, . Location in patent: Page/Page column 47-48
[6] Patent: WO2012/3189, 2012, A1, . Location in patent: Page/Page column 109-111
[7] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 21, p. 6855 - 6868
[8] European Journal of Medicinal Chemistry, 2016, vol. 108, p. 154 - 165
[9] Patent: CN105254613, 2016, A, . Location in patent: Paragraph 0046;0047; 0048; 0049; 0050; 0051
[10] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 22, p. 5861 - 5872
[11] Patent: WO2017/31325, 2017, A1, . Location in patent: Paragraph 0569
[12] Organometallics, 2017, vol. 36, # 17, p. 3429 - 3434
  • 26
  • [ 22282-99-1 ]
  • [ 865156-50-9 ]
Reference: [1] Chemical Science, 2013, vol. 4, # 8, p. 3269 - 3274
[2] Patent: WO2015/181797, 2015, A1,
  • 27
  • [ 22282-99-1 ]
  • [ 946000-13-1 ]
Reference: [1] Patent: WO2008/57469, 2008, A1,
[2] Patent: WO2008/57468, 2008, A1,
  • 28
  • [ 22282-99-1 ]
  • [ 67-56-1 ]
  • [ 448906-60-3 ]
Reference: [1] Journal of Medicinal Chemistry, 2014, vol. 57, # 1, p. 110 - 130
[2] Patent: WO2009/24905, 2009, A1, . Location in patent: Page/Page column 75; 80-81
[3] Patent: US2011/212998, 2011, A1, . Location in patent: Page/Page column 27
[4] Patent: WO2009/109872, 2009, A1, . Location in patent: Page/Page column 29
  • 29
  • [ 22282-99-1 ]
  • [ 105-58-8 ]
  • [ 1060814-91-6 ]
YieldReaction ConditionsOperation in experiment
83% With lithium diisopropyl amide In tetrahydrofuran; n-heptane; ethylbenzene at -70℃; for 2 h; Intermediate 331 -(4-Bromo-pyridin-2-yl)-cvclopropanecarboxylic acid ethyl esterStep 1 : (4-bromo-pyridin-2-yl)-acetic acid ethyl ester; Lithium diisopropylamide (2 mol/L in tetrahydrofuran/heptane/ethylbenzene, 3.00 mL) was added to a solution of 4-bromo-2-methylpyridine (2.00 g) and diethyl carbonate (1 .8 mL) in tetrahydrofuran (30 mL) cooled to -70 'C. The solution was stirred for 1 h prior to the addition of another portion of lithium diisopropylamide (2 mol/L in tetrahydrofuran/heptane/ ethylbenzene, 3.00 mL). Stirring was continued at -70 °C for one more hour and then the reaction was quenched by the addition of water. The resulting mixture was extracted with ethyl acetate and the combined extracts were washed with brine and dried (Na2S04). The solvent was evaporated and the residue was chromatographed on silica gel(cyclohexane/ethyl acetate 95:5-->1 :1 ) to give the title compound. Yield: 2.35 g (83percent of theory); LC (method 3): tR = 2.86 min; Mass spectrum (ESI+): m/z = 244/246 (Br) [M+H]+.
46% With lithium diisopropyl amide In tetrahydrofuran at -60℃; for 2 h; To a solution of 4-bromo-2-methyl-pyridine (2.00 g, 11.6 mmol, CAS 22282-99- 1) and diethyl carbonate (1.65 g, 13.9 mmol, 1.68 mL) in THF (15.0 mL) was added LDA (2 M, 11.63 mL) at -60 °C dropwise. Then the mixture was stirred at -60 °C for 2 hours. On completion, the reaction mixture was quenched by addition of saturated ammonium chloride solution 30 mL at 0 °C, and extracted with ethyl acetate 60 mL (3 X 20 mL). The combined organic layer was dried over anhydrous sodium sulfate, filtered and concentrated under in vacuo to give a residue. The residue was purified by column chromatography (petroleum ether:ethyl acetate = 20:1 to 8:1) to give the title compound (1.30 g, 46percent yield) as a yellow oil.1H NMR (400MHz, CDCl3) δ = 8.40 (d, J = 5.2 Hz, 1H), 7.52 (d, J = 1.6 Hz, 1H), 7.40 (dd, J = 1.6, 5.2 Hz, 1H), 4.21 (q, J = 7.2 Hz, 2H), 3.83 (s, 2H), 1.29 (t, J = 7.2 Hz, 3H).
Reference: [1] Patent: WO2011/159760, 2011, A1, . Location in patent: Page/Page column 73
[2] Patent: WO2018/106636, 2018, A1, . Location in patent: Paragraph 00244
[3] Patent: WO2017/74833, 2017, A1, . Location in patent: Page/Page column 61; 80; 81
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 22282-99-1 ]

Bromides

Chemical Structure| 502509-20-8

[ 502509-20-8 ]

4-Bromo-2-vinylpyridine

Similarity: 0.98

Chemical Structure| 156761-88-5

[ 156761-88-5 ]

4-Bromo-2-ethylpyridine

Similarity: 0.91

Chemical Structure| 17117-23-6

[ 17117-23-6 ]

4-Bromo-2,5-dimethylpyridine

Similarity: 0.89

Chemical Structure| 865156-50-9

[ 865156-50-9 ]

(4-Bromopyridin-2-yl)methanamine

Similarity: 0.87

Chemical Structure| 259807-91-5

[ 259807-91-5 ]

4-Bromo-2,3-dimethylpyridine

Similarity: 0.87

Related Parent Nucleus of
[ 22282-99-1 ]

Pyridines

Chemical Structure| 502509-20-8

[ 502509-20-8 ]

4-Bromo-2-vinylpyridine

Similarity: 0.98

Chemical Structure| 156761-88-5

[ 156761-88-5 ]

4-Bromo-2-ethylpyridine

Similarity: 0.91

Chemical Structure| 17117-23-6

[ 17117-23-6 ]

4-Bromo-2,5-dimethylpyridine

Similarity: 0.89

Chemical Structure| 865156-50-9

[ 865156-50-9 ]

(4-Bromopyridin-2-yl)methanamine

Similarity: 0.87

Chemical Structure| 259807-91-5

[ 259807-91-5 ]

4-Bromo-2,3-dimethylpyridine

Similarity: 0.87